Variant report
Variant | esv3381497 |
---|---|
Chromosome Location | chr4:86816024-86816268 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558786235 | chr4:86816051-86816052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11097081 | chr4:86816074-86816075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570656677 | chr4:86816089-86816090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113023438 | chr4:86816126-86816127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs199958793 | chr4:86816127-86816128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79963570 | chr4:86816131-86816132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9307012 | chr4:86816133-86816134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540459367 | chr4:86816140-86816141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs372164773 | chr4:86816141-86816142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371057406 | chr4:86816142-86816143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs199832322 | chr4:86816147-86816148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373934363 | chr4:86816153-86816154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145429922 | chr4:86816154-86816155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374851495 | chr4:86816164-86816165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369090305 | chr4:86816165-86816166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534777481 | chr4:86816168-86816169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10015778 | chr4:86816170-86816171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185381696 | chr4:86816193-86816194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541556086 | chr4:86816198-86816199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143570441 | chr4:86816216-86816217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575000881 | chr4:86816220-86816221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574860091 | chr4:86816221-86816222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6531876 | chr4:86816250-86816251 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Prostate cancer | 16573809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:86790800-86835400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr4:86791200-86844400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr4:86808200-86846000 | Weak transcription | HUVEC | blood vessel |
4 | chr4:86811200-86822800 | Weak transcription | Primary B cells from cord blood | blood |
5 | chr4:86812200-86825000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr4:86812200-86831200 | Weak transcription | Primary B cells from peripheral blood | blood |
7 | chr4:86812400-86831000 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr4:86814200-86822000 | Weak transcription | NHDF-Ad | bronchial |
9 | chr4:86815400-86825400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr4:86815800-86816400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr4:86815800-86831000 | Weak transcription | Fetal Muscle Trunk | muscle |
12 | chr4:86815800-86842800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr4:86816000-86817800 | Weak transcription | Pancreas | Pancrea |